New 5-Modified Pyrimidine Nucleoside Inhibitors of Mycobacterial Growth

Cover Page

Abstract


The WHO has declared tuberculosis (TB) a global health emergency. Therefore, there is an urgent need to discover and develop new anti-TB drugs. Here we report a new category of 5-substituted pyrimidine nucleosides as potent inhibitors of Mycobacterium tuberculosis growth in vitro. A series of 2'-deoxy-, 3'-azido-2',3'-dideoxy-, and 3'-amino-2',3'-dideoxypyrimidine nucleoside analogues bearing lengthy flexible alkyloxymethyl substituents exhibited marked inhibitory activity against M tuberculosis in vitro. 5-Dodecyloxymethyl-2'-deoxyuridine was found to be a potent inhibitor of M. tuberculosis propagation in vitro. In contrast, monophosphates of the tested nucleosides were devoid of antimycobacterial activity. This new class of inhibitors seems to be a promising chemotherapeutic agent against TB and merits further studies.

New 5-Modified Pyrimidine Nucleoside Inhibitors of Mycobacterial Growth

L A Alexandrova

Engelhardt Institute of Molecular Biology, Russian Academy of Sciences

Email: ala200407@mail.ru
ul. Vavilova 32, Moscow, 119991, Russia

E R Shmalenyuk

Engelhardt Institute of Molecular Biology, Russian Academy of Sciences

ul. Vavilova 32, Moscow, 119991, Russia

S N Kochetkov

Engelhardt Institute of Molecular Biology, Russian Academy of Sciences

ul. Vavilova 32, Moscow, 119991, Russia

V V Erokhin

Central Tuberculosis Research Institute, Russian Academy of Medical Sciences

Yauzskaya alley 2, Moscow, 107564, Russia

T G Smirnova

Central Tuberculosis Research Institute, Russian Academy of Medical Sciences

Yauzskaya alley 2, Moscow, 107564, Russia

S N Andreevskaia

Central Tuberculosis Research Institute, Russian Academy of Medical Sciences

Yauzskaya alley 2, Moscow, 107564, Russia

L N Chernousova

Central Tuberculosis Research Institute, Russian Academy of Medical Sciences

Yauzskaya alley 2, Moscow, 107564, Russia

  1. Word Health Org., http://www/who/int/mediacentre/fastsheets/fs104/en/.2005
  2. Banerjee R., Schecter G.F., Flood J., Porco T.C. // Expert Rev Anti Infect Ther. 2008. V. 6. P. 713-724.
  3. Bucher H.C., Griffith L.E., Guyatt G.H., et al // AIDS 1999, V. 13. P. 501-507.
  4. Daley C.L., Small P.M., Schecter G.F., et al // N. Engl. J. Med. 1992. V. 326. P. 231-235.
  5. Ginsberg A.M., Spigelman M. // Nat Med. 2007. V. 13. P. 290-294.
  6. Tsuyuguchi I. // Tuberculosis (Edinb). 2001. V. 81. P. 221-227.
  7. Tuberculosis in Russia. “Prima” Moscow, 2009
  8. De Clercq E. // Adv Virus Res. 2009. V. 73. P. 1-53.
  9. Van Calenbergh S. // Verh K Acad Geneeskd Belg. 2006. V. 68. P. 223-248.
  10. Gupte A., Boshoff H.I., Wilson D.J., et al // J. Med. Chem. 2008, V. 51, P. 7495-7507
  11. Rai D., Johar M., Manning T., et al // J. Med. Chem. 2005, V. 48, P. 7012-7017.
  12. Rai D., Johar M., Srivastav N.C., et al // J. Med. Chem. 2007, V. 50, P. 4766-4774
  13. Johar M., Manning T., Tse C., et al // J. Med. Chem. 2007, V. 50, H. 3696-3705.
  14. Srivastav N.C., Manning T., Kunimoto D.Y., Kumar R. // Bioorganic & Medical Chemistry, 2007, V. 15, P. 2045-2053
  15. Alexandrova L.A., Skoblov A.Yu., Jasko M.V., Victorova L.S., Krayevsky A.A. // Nucl. Acids Res., 1998, V. 26, P. 778-786.
  16. Dyatkina N.B., von Janta-Lipinski M., Minasyan Sh.H., et al // Bioorg. Khim., 1987. V. 13. P. 1366-1374.
  17. Andreevskaia S.N., Chernousova L.N., Smirnova T.G., Larionova E.E., Kuz’min A.V. // Probl Tuberk Bolezn Legk. 2006;(12): 43-48.

Views

Abstract - 201

PDF (English) - 88

PDF (Russian) - 103

Cited-By


PlumX

Dimensions

Refbacks

  • There are currently no refbacks.

Copyright (c) 2010 Alexandrova L.A., Shmalenyuk E.R., Kochetkov S.N., Erokhin V.V., Smirnova T.G., Andreevskaia S.N., Chernousova L.N.

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies